AntiCoagulation Europe (UK)

AntiCoagulation Europe (UK)

ABOUT US

Contact us

ANTIPLATELET THERAPY

Educational Films

What are anticoagulants?


Anticoagulants are a type of drug that reduces the body's ability to form clots in the blood.

They do this by inhibiting the production of vitamin K in the liver. This increases the time your blood takes to clot.Image: inside a blood vessel

Although they are sometimes called blood thinners, they do not actually thin the blood.

Furthermore, this type of medicine will not dissolve clots that already have formed, although it will stop an existing clot from getting larger.

 

Why you may need anticoagulants


You may need to use warfarin or other anticoagulants if you have been diagnosed with or treated for one or more of the following:

  1. Atrial fibrillation (AF)
  2. Artificial heart valve (AVR or MVR)
  3. Deep vein thrombosis (DVT)
  4. Pulmonary embolism (PE)
  5. Prevention of blood clots e.g. genetic clotting disorders
  6. Stroke
  7. Heart Attack

Sometimes it is only necessary to take anticoagulants for a few months. In other circumstances you will take them for life. Your health care professional will tell you how long to take them for. Do not stop taking them unless you are told to you.

Anticoagulant drugs affect the blood's ability to clot and therefore there is an increased risk of bleeding for people who are taking them. Because of this risk, it is vitally important to take the tablets exactly as directed.

Never take larger or more frequent doses.

 

How will my treatment be monitored?


Image: mother and daughterYour treatment is monitored by regular blood testing. The INR is then measured and recorded in your Anticoagulant Therapy Record Book. Your warfarin dosage will be adjusted up or down depending on the result of your blood test: if the INR is too low, the warfarin dose is increased; if it is too high the dose is decreased.

No two people are the same and you may need a higher or lower dose than someone else to achieve the same result.

You will need to have regular blood tests to check the blood's clotting ability. The results of these tests will help your Doctor determine the proper dose of the drug to be taken each day. The test result may be referred to as your INR.

 

What does INR mean?


It stands for International Normalised Ratio (INR) and is a measure of how much longer it takes the blood to clot when oral anticoagulation is used. For example, if your INR is 2 the blood is taking twice as long as normal to clot. Everyone needs a unique dosage of anticoagulant, which needs to be kept at a stable level.

You will be given a therapeutic range this will vary depending on the condition for which you are taking anticoagulants. Within that range you will have a target INR. For example if your therapeutic range was 2 to 3 then your target INR would be 2.5. It is important to keep within your therapeutic range. If your result is above that range then you are at an increased risk o bleeding and if your result is lower than then you are at an increased risk of clotting.

People who are taking anticoagulant drugs should tell all doctors, dentists, pharmacists, and other medical professionals who provide medical treatments or services to them that they are taking this medicine. They should also carry identification stating that they are using an anticoagulant drug.

Do not take any other prescription or over-the-counter medicine (especially aspirin) without first telling the Pharmacist that you are taking anticoagulation therapy. This also applies to medicines that you may think of harmless such as cough medicine.

 

Is the treatment safe?

Image: testing a blood sample
Anticoagulant therapy is safe as long as you follow the advice of your anticoagulant clinic and/or the advice in your Anticoagulant Therapy Record Book. You will need to have your blood tested at regular intervals at an anticoagulant clinic or at home by self-testing. Your INR reading may vary, but will need to be kept within a certain range decided by your GP or consultant.

 

Are there any side effects?


The most common side effects of warfarin are bleeding and bruising. This will normally occur when you go out of your therapeutic range. However sometimes bleeding can occur when you are still within range. It can be in the form of prolonged bleeding from cuts, bleeding that does not stop by itself, nose bleeds, small or large bruises under the skin, bleeding gums when brushing the teeth, red or dark brown urine, red or black stools, or coughing or vomiting bloodstained fluid. Any of these should be reported to your clinic.

In the event of prolonged bleeding, you must inform your GP or haematologist, or go to the nearest casualty department for urgent treatment.
 

AntiCoagulation Europe produces the following booklets:

  • Living with Warfarin
  • Living with Atrial Fibrillation
  • Living with Prosthetic Valves

Copies are available for £1.00 per item for members and £1.30 for non members (including postage and packing) from:

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP.

anticoagulation@ntlworld.com

Copyright AntiCoagulation Europe 2006
Registered Charity No 1090250

Text too small? Click here.

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP | Tel: 020 8289 6875


PLEASE NOTE THIS WEBSITE SHOULD NOT BE USED TO REPLACE ADVICE FROM YOUR DOCTOR

We welcome feedback about our website. Please email your comments to anticoagulation@ntlworld.com

 

Contact us by email

 

Contact us by post, phone or fax

 

What is atrial fibrillation?

 

About Cardioversion

 

ABout Ablation

 

Lionel

 

TIPS TO HELP YOU AVOID A DVT

 

TRAVELLER'S THROMBOSIS

 

Stress and heart disease

 

Medical Alert identity Card

 

MARIANNE GILL

 

John Kelman

 

MICHAEL KNIGHT

 

Evelyn Richardson

 

Max Crompton

 

1. Introduction

 

2. Overview

 

3. How to Roll out a near-patient testing service in Primary care

 

4. The importance of quality control and assurance and Selecting a POC device

 

5. Rolling out a Patient self-testing service

 

6. The patient's perspective

 

7. A personal account

 

8. Conclusion

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

A guide to setting up Near Patient Testing in Primary Care

 

NICE guidelines for atrial fibrillation

 

Near patient Testing in Tayside

 

Patients capable of self-testing: a systematic review

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

NICE guidance on Venous Thromboembolism (VTE)

 

Venous thromboembolism CMO press release

 

Front Line in Stroke Prevention - Report

 

New hope for early detection of deep vein thrombosis

 

NICE guidelines for atrial fibrillation

 

Ongoing trials for new oral anticoagulant

 

Expert pharmacists get the go-ahead

 

Patients capable of self-testing: a systematic review

 

News archive

 

'Strips on prescription' resource pack

 

Abolition of prescription charges

 

Equality for the Republic of Ireland

 

It's about time

 

It's about time survey

 

Conference 2008

 

Flora London MArathon 2008

 

CoaguNation Bus Tour

 

Roche Diagnostics launches CoaguNation Club

 

INR Test Monitors

 

Breaking news